biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	56A665D1-F38C-44B7-9036-F89F8A30B3E3
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-LG-A9QD-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-LG-A9QD-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-LG-A9QD-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104786
biospecimen__bio__day_of_creation	30
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-LG-A9QD.D5BAD949-7001-4FAC-A7B4-E9B426A53A76.pdf
biospecimen__bio__plate_column	11
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	B
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-LG-A9QD
biospecimen__shared__patient_id	A9QD
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	BBCA1334-DBBE-429F-B887-6116E108D829
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.4
clinical__chol_lihc_shared__albumin_result_specified_value	2.9
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Single
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__bcr_followup_barcode	TCGA-LG-A9QD-F69200
clinical__clin_shared__bcr_followup_uuid	F9C87B9D-3A10-47F6-9D77-C6A9CD26BB6A
clinical__clin_shared__cancer_first_degree_relative	3
clinical__clin_shared__day_of_form_completion	7
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	320
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__rx__bcr_drug_barcode	TCGA-LG-A9QD-D60838
clinical__rx__bcr_drug_uuid	CD39633C-91A8-4F9F-B06B-08ECCCD2300D
clinical__rx__days_to_drug_therapy_start	61
clinical__rx__drug_name	Sorafinib ( Nexavar)
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	09d3b24a-f9c0-402f-a3c0-daec0e7098fa
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-LG-A9QD-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	fa6524a5-d5b0-43a3-a708-50cb64c5fbfb
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.84
gdc__analytes__analyte_id	ecc9bd09-4f67-4230-8c5e-3208281499c5
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	948a9bbc-60b0-4fb7-a707-76bc41294217
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	0aac631c-1931-5ee8-ac95-e3d4cfcf1b89
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1945
gdc__diagnoses__age_at_diagnosis	24969
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24969.0
gdc__diagnoses__days_to_last_follow_up	366.0
gdc__diagnoses__diagnosis_id	d28e833a-d213-5a32-abaf-ab7a91dcbecc
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	26.218820861678005
gdc__exposures__exposure_id	d2bbdf5a-4656-58c3-9dd2-3ad286382614
gdc__exposures__height	168.0
gdc__exposures__weight	74.0
gdc__file_id	b2c6f006-f9de-4917-83d3-03858b728fe3
gdc__file_name	982dd56f-fbe2-4ca5-8b6d-1028faec1872.mirbase21.mirnas.quantification.txt
gdc__file_size	50188
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	3232df3ecd0b60bafc4dc9c003689eb6
gdc__portions__is_ffpe	false
gdc__portions__portion_id	1912234b-1c31-4695-a9a0-207c8272bbeb
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	28
gdc__samples__initial_weight	1580.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	D5BAD949-7001-4FAC-A7B4-E9B426A53A76
gdc__samples__sample_id	3b829cbd-1abb-41f8-9633-597e6b79e362
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	1.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	3.0
gdc__slides__percent_tumor_cells	96.0
gdc__slides__percent_tumor_nuclei	97.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	0e90ad01-6489-4bb0-a0da-d622f3e8682f
gdc__submitter_id	mirna_swap_dr11_169_MirnaExpression2a34e275-397e-468b-8bb6-1790491f640a_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	LG
gdc__tissue_source_site__name	Hartford Hospital
gdc__tissue_source_site__tissue_source_site_id	ef6a28c0-1733-5c00-be40-0ea911305be8
gdc__treatments__treatment_id	627ce4f3-300f-5e40-8148-1416bca09c74
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:06:58.334+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/09d3b24a-f9c0-402f-a3c0-daec0e7098fa-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/09d3b24a-f9c0-402f-a3c0-daec0e7098fa-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129559
manually_curated__local_md5	7d384f7d9c524b3816252cf912bebae3
manually_curated__opengdc_download_date	2018-10-16T17:11:03.000986+02:00
manually_curated__opengdc_file_md5	9be1f6d95bf5ddc34d623285cd0daf9f
manually_curated__opengdc_file_size	50187
manually_curated__opengdc_id	09d3b24a-f9c0-402f-a3c0-daec0e7098fa-meq
manually_curated__origin_file_size	129559
manually_curated__origin_last_modified_date	Tue Oct 16 18:08:00 CEST 2018
manually_curated__origin_md5	7d384f7d9c524b3816252cf912bebae3
manually_curated__tissue_status	tumoral
